Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

EMEA initiates review of Amsterdam MolecularTherapeutics' MAA for Glybera in LPLD

Jan. 27, 2010

Transition Therapeutics reports results from phase II trial of TT-223 in type 2 diabetes

Jan. 26, 2010

CHMP recommends suspension of marketing authorization for sibutramine

Jan. 26, 2010

Osiris completes enrollment in phase II trial of Prochymal in type 1 diabetes

Jan. 26, 2010

Affymax completes treatment in phase III trial of Hematide for anemia in CRF

Jan. 26, 2010

FDA sets PDUFA date for Genzyme's BLA for Lumizyme

Jan. 26, 2010

Pharming presents update on European CHMP's review of MAA for Rhucin in HAE

Jan. 25, 2010

GAA gene variants responsive to Pompe's disease candidate AT-2220 identified

Jan. 25, 2010

Gentamicin induces readthrough of termination codons in Stuve-Wiedermann syndrome

Jan. 25, 2010

GPR119 agonists for the treatment of obesity identified by iNovacia

Jan. 25, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...